These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 33405316)

  • 1. Multifunctional intracellular matrix metalloproteinases: implications in disease.
    Bassiouni W; Ali MAM; Schulz R
    FEBS J; 2021 Dec; 288(24):7162-7182. PubMed ID: 33405316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac sarcomeric proteins: novel intracellular targets of matrix metalloproteinase-2 in heart disease.
    Ali MA; Fan X; Schulz R
    Trends Cardiovasc Med; 2011 May; 21(4):112-8. PubMed ID: 22681966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase inhibitor properties of tetracyclines: therapeutic potential in cardiovascular diseases.
    Castro MM; Kandasamy AD; Youssef N; Schulz R
    Pharmacol Res; 2011 Dec; 64(6):551-60. PubMed ID: 21689755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial matrix metalloproteinase-2: inside out and upside down.
    DeCoux A; Lindsey ML; Villarreal F; Garcia RA; Schulz R
    J Mol Cell Cardiol; 2014 Dec; 77():64-72. PubMed ID: 25261607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear localization of matrix metalloproteinases.
    Mannello F; Medda V
    Prog Histochem Cytochem; 2012 Mar; 47(1):27-58. PubMed ID: 22226510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases.
    Cauwe B; Opdenakker G
    Crit Rev Biochem Mol Biol; 2010 Oct; 45(5):351-423. PubMed ID: 20812779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there new hope for therapeutic matrix metalloproteinase inhibition?
    Vandenbroucke RE; Libert C
    Nat Rev Drug Discov; 2014 Dec; 13(12):904-27. PubMed ID: 25376097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology.
    de Almeida LGN; Thode H; Eslambolchi Y; Chopra S; Young D; Gill S; Devel L; Dufour A
    Pharmacol Rev; 2022 Jul; 74(3):712-768. PubMed ID: 35738680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases.
    Zitka O; Kukacka J; Krizkova S; Huska D; Adam V; Masarik M; Prusa R; Kizek R
    Curr Med Chem; 2010; 17(31):3751-68. PubMed ID: 20846107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature.
    Chow AK; Cena J; Schulz R
    Br J Pharmacol; 2007 Sep; 152(2):189-205. PubMed ID: 17592511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and silencing of matrix metalloproteinases.
    Fu X; Parks WC; Heinecke JW
    Semin Cell Dev Biol; 2008 Feb; 19(1):2-13. PubMed ID: 17689277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
    Siasos G; Tousoulis D; Kioufis S; Oikonomou E; Siasou Z; Limperi M; Papavassiliou AG; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1132-48. PubMed ID: 22519444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix Metalloproteinases in Non-Neoplastic Disorders.
    Tokito A; Jougasaki M
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of matrix metalloproteinases in cardiovascular diseases].
    Groblewska M; Tycińska A; Mroczko B; Musiał W; Szmitkowski M
    Pol Merkur Lekarski; 2011 Apr; 30(178):235-40. PubMed ID: 21595165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and Biological Attributes of Matrix Metalloproteinases.
    Cui N; Hu M; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of matrix metalloproteinases (MMPs) as a potential strategy to ameliorate hypertension-induced cardiovascular alterations.
    Castro MM; Tanus-Santos JE
    Curr Drug Targets; 2013 Mar; 14(3):335-43. PubMed ID: 23316965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases at a glance.
    Hey S; Linder S
    J Cell Sci; 2024 Jan; 137(2):. PubMed ID: 38236162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
    Narula S; Tandon C; Tandon S
    Curr Med Chem; 2018; 25(15):1805-1816. PubMed ID: 29210632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New intracellular activities of matrix metalloproteinases shine in the moonlight.
    Jobin PG; Butler GS; Overall CM
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):2043-2055. PubMed ID: 28526562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.